Impact of estrogen receptor levels on outcome in triple negative breast cancer patients treated with (neo)adjuvant chemotherapy

被引：0
|
作者：
Griguolo, Gaia [1 ]
Dieci, Maria Vittoria [1 ]
Bottosso, Michele [1 ]
Tsvetkova, Vassilena [1 ]
Giorgi, Carlo Alberto [2 ]
Angelini, Silvia [2 ]
Tasca, Giulia [2 ]
Cumerlato, Enrico [1 ]
Lo Mele, Marcello [3 ]
Conte, PierFranco [1 ]
Guarneri, Valentina [1 ]
机构：
[1] Univ Padua, Padua, Italy
[2] Ist Oncol Veneto IRCCS, Padua, Italy
[3] Azienda Osped Padova, Padua, Italy
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-P3-08-05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-08-05
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients
    David S. P. Tan
    Caterina Marchió
    Robin L. Jones
    Kay Savage
    Ian E. Smith
    Mitch Dowsett
    Jorge S. Reis-Filho
    Breast Cancer Research and Treatment, 2008, 111 : 27 - 44
  • [32] Triple negative breast cancer:: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients
    Tan, David S. P.
    Marchio, Caterina
    Jones, Robin L.
    Savage, Kay
    Smith, Ian E.
    Dowsett, Mitch
    Reis-Filho, Jorge S.
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 111 (01) : 27 - 44
  • [33] Prognostic analysis of triple-negative breast cancer patients treated with adjuvant chemotherapy of fluorouracil, epirubicin and cyclophosphamide
    Sun, Weiling
    Li, Chunhong
    Liu, Meiyan
    Liu, Wei
    Yang, Chunyu
    Cai, Li
    ONCOLOGY LETTERS, 2016, 11 (03) : 2320 - 2326
  • [34] Fertility preservation does not delay the initiation of chemotherapy in breast cancer patients treated with adjuvant or neo-adjuvant chemotherapy
    Cynthia D’Hondt
    Marian Vanhoeij
    Ellen Van Moer
    Ingrid Segers
    Christel Fontaine
    Herman Tournaye
    Michel De Vos
    Breast Cancer Research and Treatment, 2020, 184 : 433 - 444
  • [35] Fertility preservation does not delay the initiation of chemotherapy in breast cancer patients treated with adjuvant or neo-adjuvant chemotherapy
    D'Hondt, Cynthia
    Vanhoeij, Marian
    Van Moer, Ellen
    Segers, Ingrid
    Fontaine, Christel
    Tournaye, Herman
    De Vos, Michel
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 184 (02) : 433 - 444
  • [36] Triple negative breast cancer: adjuvant chemotherapy effect on survival
    Steponaviciene, L.
    Lachej-Mikeroviene, N.
    Smailyte, G.
    Aleknavicius, E.
    Meskauskas, R.
    Didziapetriene, J.
    ADVANCES IN MEDICAL SCIENCES, 2011, 56 (02): : 285 - 290
  • [37] Neoadjuvant Versus Adjuvant Chemotherapy for Triple Negative Breast Cancer
    Kennedy, Carlie R.
    Gao, Feng
    Margenthaler, Julie A.
    JOURNAL OF SURGICAL RESEARCH, 2010, 163 (01) : 52 - 57
  • [38] Extended Adjuvant Chemotherapy in Triple-Negative Breast Cancer
    Locatelli, Marzia A.
    Curigliano, Giuseppe
    Eniu, Alexandru
    BREAST CARE, 2017, 12 (03) : 152 - 158
  • [39] Efficacy of adjuvant chemotherapy according to prion protein expression in patients with estrogen receptor-negative breast cancer
    Meslin, F.
    Conforti, R.
    Mazouni, C.
    Morel, N.
    Tomasic, G.
    Drusch, F.
    Yacoub, M.
    Sabourin, J. C.
    Grassi, J.
    Delaloge, S.
    Mathieu, M. C.
    Chouaib, S.
    Andre, F.
    Mehrpour, M.
    ANNALS OF ONCOLOGY, 2007, 18 (11) : 1793 - 1798
  • [40] Regional differences in neo/adjuvant chemotherapy timing in patients with early-stage triple-negative breast cancer in England
    Mirza, Laaeba
    Steventon, Luke
    Roylance, Rebecca
    Hughes, Chantelle
    Creed, Chiara
    Morris, Emma
    Purcell, Ian
    Frank, Suzanne
    Masters, Neil
    Chambers, Pinkie
    BREAST CANCER RESEARCH AND TREATMENT, 2025, 209 (01) : 139 - 146
12345